Nuzolvence For Suspension
Product Images NDC 68547-915

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Nuzolvence (NDC 68547-915). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by La Jolla Pharmaceutical Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Nuzolvence 01)

Chemical structure diagram of zoliflodacin, the active ingredient in NUZOLVENCE for suspension oral medication. The structure includes heterocyclic rings, fluorine substitution, and multiple nitrogen, oxygen, and sulfur atoms depicted with bonds and stereochemistry indicators.*

FDA Label Image

Figure (Nuzolvence 02)

An illustration showing packaging and mixing components for NUZOLVENCE (zoliflodacin) oral suspension 3 g/1. The image depicts a packet containing NUZOLVENCE medicine alongside a mixing container with measurement markings and a lid, intended for preparing the oral suspension.*

FDA Label Image

Figure (Nuzolvence 03)

An instructional diagram showing the measurement and preparation process for NUZOLVENCE (zoliflodacin) oral suspension. The image includes a cup marked with liquid volume measurements and a close-up view of a label or instruction sheet detailing preparation or usage steps.*

FDA Label Image

Figure (Nuzolvence 04)

An instructional diagram showing a measuring cup being filled with liquid from a faucet. A close-up circular inset highlights the 60 mL measurement mark on the cup, emphasizing the volume to be measured.*

FDA Label Image

Figure (Nuzolvence 05)

An instructional illustration showing two steps: (a) shaking a packet or pouch with visible motion lines around it, and (b) tearing open the packet along a corner using scissors. The packet appears rectangular with partially visible text or graphics.*

FDA Label Image

Figure (Nuzolvence 06)

An instructional illustration showing the preparation of NUZOLVENCE (zoliflodacin) oral suspension. The image depicts pouring the powder from a sachet or packet into a graduated measuring cup containing liquid, indicating how to mix the suspension before administration.*

FDA Label Image

Figure (Nuzolvence 07)

An instructional illustration showing a hand twisting a child-resistant cap on a measuring cup used for oral suspension. The image highlights the action "twist tight" with an arrow indicating the direction to close the cap securely.*

FDA Label Image

Figure (Nuzolvence 08)

An instructional diagram showing a hand holding a suspension bottle labeled NUZOLVENCE, with arrows indicating shaking the bottle up and down. A stopwatch icon displays "60 sec," illustrating the shaking duration for the oral suspension before use.*

FDA Label Image

Figure (Nuzolvence 09)

An illustration showing a measuring cup for oral suspension with volume markings up to 100 mL. The image highlights visually checking the suspension level in the cup, indicated by an eye symbol pointing to the liquid measurement.*

FDA Label Image

Figure (Nuzolvence 10)

An instructional illustration showing a hand twisting off the cap of a medication suspension bottle, labeled 'twist off.' The bottle has visible measurement markings to indicate dosage volume.*

FDA Label Image

Figure (Nuzolvence 11)

An instructional illustration showing a person drinking from a measuring cup labeled with volume markings, with an arrow indicating the drink action. The text "Drink 1 of 2" appears above, suggesting a step in dosage administration.*

FDA Label Image

Figure (Nuzolvence 12)

Illustration showing steps for measuring and administering a liquid suspension using a dosing cup and dropper. The left part (a) depicts drawing liquid from a container with a dropper, and the right part (b) demonstrates shaking the dosing cup up and down before use.*

FDA Label Image

Figure (Nuzolvence 13)

An instructional illustration depicting a hand twisting the cap off a bottle, indicating the 'twist off' action for opening the container.*

FDA Label Image

Figure (Nuzolvence 14)

An instructional illustration showing a person drinking the full contents of a medication suspension from a small cup. The image includes a curved arrow indicating the drinking motion and text emphasizing that no medicine should be left over. This diagram is likely demonstrating proper administration of the NUZOLVENCE zoliflodacin oral suspension.*

FDA Label Image

Figure (Nuzolvence 15)

An instructional illustration showing an opened oral suspension bottle, a dosing cup, and a medication package being discarded into a trash bin, indicating disposal instructions for the product NUZOLVENCE (zoliflodacin) oral suspension by La Jolla Pharmaceutical Company.*

FDA Label Image

Principal Display Panel (3 g Packet Carton)

The image shows the packaging label for NUZOLVENCE (zoliflodacin) 3 g oral suspension, a unit-dose kit by La Jolla Pharmaceutical Company. The label prominently displays the product name, strength (3 g), and dosage form. Instructions indicate the kit contains a packet of zoliflodacin, a mixing container, instructions for use, and a medication guide. The packaging includes pharmacist dispensing instructions and the Entasis Therapeutics logo. The NDC number 68547-915-10 and the Rx Only designation are visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.